Exploring the role of m6A modification in cancer

被引:8
|
作者
Wei, Yongqi [1 ]
Li, Yin [1 ]
Lu, Chunlai [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China
基金
上海市自然科学基金;
关键词
cancer; disease mechanisms; post-translational modifications; methods; SINGLE-NUCLEOTIDE-RESOLUTION; MESSENGER-RNA STABILITY; PROMOTES GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; TRANSLATION; METTL14; PROGRESSION; SUPPRESSES; DIFFERENTIATION; DEMETHYLATION;
D O I
10.1002/pmic.202200208
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
m6A is one of the most common, abundant, and conserved post-transcriptional modifications that regulate broad biological processes in the human body through m6A regulators. m6A regulators are figuratively classified according to their functions: writers, erasers, and readers, which can methylate RNAs, demethylate RNAs, and recognize RNA m6A sites, consequently affecting RNA fate. Tumors are an essential class of diseases that threaten human health, and as the study of m6A modification in tumors continues to advance, more and more relevant studies are emerging. In this review, we overview the recent studies of m6A in various types of tumors to demonstrate the role of m6A modification in providing a vision in diagnosing and treating tumors.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] The regulatory mechanism of m6A modification in gastric cancer
    Wu, Si
    Li, Chunming
    Zhou, Hanghao
    Yang, Ying
    Liang, Na
    Fu, Yue
    Luo, Qingqing
    Zhan, Yali
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [32] Epigenetic modification of m6A regulator proteins in cancer
    Wang, Yumin
    Wang, Yan
    Patel, Harsh
    Chen, Jichao
    Wang, Jinhua
    Chen, Zhe-Sheng
    Wang, Hongquan
    MOLECULAR CANCER, 2023, 22 (01)
  • [33] Targeting the RNA m6A modification for cancer immunotherapy
    Xinxin Li
    Shoubao Ma
    Youcai Deng
    Ping Yi
    Jianhua Yu
    Molecular Cancer, 21
  • [34] Crosstalk between m6A modification and autophagy in cancer
    Tao Chen
    Liying Zheng
    Peiyue Luo
    Jun Zou
    Wei Li
    Qi Chen
    Junrong Zou
    Biao Qian
    Cell & Bioscience, 14
  • [35] The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
    Tong, Huan
    Wei, He
    Smith, Alhaji Osman
    Huang, Juan
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [36] m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance
    Chen, Chen
    Guo, Yuying
    Guo, Yaxin
    Wu, Xiaoke
    Si, Chaohua
    Xu, Yanxin
    Kang, Qiaozhen
    Sun, Zhenqiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Shining a spotlight on m6A and the vital role of RNA modification in endometrial cancer: a review
    Jin, Zujian
    Sheng, Jingjing
    Hu, Yingying
    Zhang, Yu
    Wang, Xiaoxia
    Huang, Yiping
    FRONTIERS IN GENETICS, 2023, 14
  • [38] The role of m6A RNA methylation in cancer
    Sun, Ting
    Wu, Ruiyan
    Ming, Liang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
  • [39] The emerging importance role of m6A modification in liver disease
    Wang, Sheng
    Gao, Songsen
    Ye, Wufei
    Li, Yueran
    Luan, Jiajie
    Lv, Xiongwen
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [40] The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis
    Fu, Jie
    Cui, Xinghui
    Zhang, Xiaoyun
    Cheng, Min
    Li, Xiaoxia
    Guo, Zhiliang
    Cui, Xiaodong
    FRONTIERS IN GENETICS, 2021, 12